New PET Scan to Find Small Bowel Tumors
Part of Cancer clinical trials.
This study tests a special PET/CT scan (68Ga-DOTATOC PET/CT-enterography) to locate neuroendocrine tumors in the small bowel more clearly. It may help identify the exact tumor site before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a neuroendocrine tumor in your small bowel.
- Your tumor can be any grade or growth rate (Ki-67).
- You are a candidate for surgery to remove the tumor.
- You do not have another active cancer at the same time.
- You do not have inflammatory bowel disease (like Crohn's or ulcerative colitis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new PET scan tracer to find neuroendocrine tumors in the body. It may help doctors see where the tumors are and plan better treatment.
This trial tests a special PET scan to better evaluate gastroenteropancreatic neuroendocrine tumors (GEP-NETs). It may help your doctor see where the tumors are in your body.
This study uses a PET/CT scan with a small amount of radioactive tracer to see how neuroendocrine tumors are behaving in adults. It may help doctors better detect and evaluate these tumors, especially when symptoms suggest a carcinoid-type hormone problem.
This trial tests a new type of PET scan using a radioactive tracer called 61Cu-NODAGA-LM3 to detect neuroendocrine tumors (NETs). The goal is to see if it works as well as or better than the standard scan. If you have a NET and need a scan for staging or treatment planning, you might be able to join.
This trial tests a new type of PET/CT scan called [68Ga]Ga-FAPI-04 to see if it can better detect high-grade neuroendocrine tumors. It is for patients whose standard scans show low uptake or who have aggressive tumor features.
This study compares two types of PET/CT scans to see which one is better at finding and staging neuroendocrine tumors. If you qualify, you will get both scans, which may help your doctor plan your treatment more accurately.
Hear when a new Neuroendocrine (NE) Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.